Biomarker Found to Be Associated with Higher COVID-19 Severity and Mortality Could Be Used to Better Manage Treatment
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage treatments and other interventions, including vaccinations. More...20 Apr 2021
Delivering Portable Chest Radiography through Glass (TG-CXR) Reduces COVID-19 Infection Risk in Hospitals
A study to understand the cost and benefit of adopting portable chest radiography through glass (TG-CXR) at a tertiary care centre during the COVID-19 pandemic has found the novel technique to be particularly beneficial. More...20 Apr 2021
COVID-19 Sweat Sensor Alerts Doctors and Patients to Impending Cytokine Storm in Real Time
Scientists have report preliminary results on a sweat sensor that acts as an early warning system for an impending cytokine storm, which could help doctors more effectively treat COVID-19 patients. More...19 Apr 2021
New Chest X-Ray Scoring System Can Be Used to Predict Outcome of COVID-19 Patients
Research has found that in the setting of high pretest probability of COVID-19 infection or with quick turnaround of rapid real-time reverse transcriptase-polymerase chain reaction (RT-PCR) COVID-19 test, chest X-ray (CXR) scoring can predict patient outcomes. More...16 Apr 2021
Ground-Breaking 'Pan-Corona Antivirals' Could Stop SARS-CoV-2 in Its Tracks When Used at First Sign of COVID-19 Symptoms
Clinical trials will shortly be launched into pivotal, cost-effective antiviral treatments for COVID-19 following the discovery of a molecule which changes the shape of the SARS-CoV-2 spike protein and in so doing inhibits the virus’ ability to enter cells. More...14 Apr 2021
Regeneron's Antibody Cocktail Injection Prevents Symptomatic COVID-19 Among Individuals Exposed to SARS-CoV-2
Regeneron Pharmaceuticals, Inc. (Tarrytown, NY, USA) has announced positive data from two Phase 3 trials of recently infected asymptomatic COVID-19 patients, evaluating REGEN-COV (casirivimab with imdevimab) 1,200 mg administered via subcutaneous (SC) administration. More...13 Apr 2021
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Mobile Barrier
Tilted Mobile Leaded Barrier
New
Monitor Cart
Tryten S5
In Other News
Blood Plasma Biomarker Discovered in Hospitalized COVID-19 Patients May Predict ARDS Severity
Portable Nasal Spray That Destroys SARS-CoV-2 Could Prove to Be Breakthrough COVID-19 Treatment
Landmark Discovery of Critical SARS-CoV-2 Enzyme in First Ever X-Ray Images Could Improve Design of New COVID-19 Drugs
Advantech Launches One-to-One Thermal Screening Kiosk with Video AI-Integrated System to Reduce Spread of COVID-19
Widely Used Transplant-Rejection Drug Cyclosporine Identified as Potential New COVID-19 Treatment
Massive X-Ray Screening Identifies Promising Candidates for Drugs Against COVID-19
AI-Based Approach Could Help Develop New Protein-Based COVID-19 Antibody Therapies
New-Baseline Chest Imaging in Discharged COVID-19 Patients Could Help Identify Those at Highest Risk of Reinfection
AI-Accelerated Method Monitors COVID-19 Disease Severity Over Time from Patient Chest CT Scans
Discovery of Cancer Drug That Lessens Toxicity of SARS-COV-2 Proteins Opens Door to Testing More Effective COVID-19 Drugs
COVID-19 Test Uses Novel High-Throughput Molecular Method for Detecting SARS-CoV-2 Infection in Saliva Samples
New COVID-19 Diagnostic Test Detects SARS-CoV-2 Virus Even When It Mutates
COVID-19 Group Testing Method Delivers Results 13 Times Faster than Individual Testing of Each Sample
X-Rays Combined with AI Offer Fast Diagnostic Tool in Detecting COVID-19
Novel 15-Minute Microfluidic DLD Assay Could Assess Severity of Immune Response to COVID-19 Infection
New Mass Spectrometry-Based Technique Enables Ultrafast Identification of COVID-19 Biomarkers
Evidence of SARS-CoV-2 Infecting Mouth’s Cells Further Confirms Reliability of Saliva Testing for Diagnosing COVID-19
AACC Issues Updated Recommendations on Uses and Limitations of COVID-19 Antibody Tests
Rapid Antigen Tests Better at Correctly Identifying COVID-19 in People with Symptoms than in People Without Symptoms
Powerful Brain Imaging Allows Researchers to Pinpoint Tissue Damage Following COVID-19 Illness
Commonly Used Antiviral and Anti-Malarial Drugs Found to Work Similarly to Gilead’s Remdesivir in Preventing SARS-CoV-2 Replication
Beckman Coulter's SARS-CoV-2 IgG II Antibody Test Receives FDA Emergency Use Authorization
First Hybridization Capture-Based Next-Generation Sequencing SARS-CoV-2 Assay Receives FDA EUA
